Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 559 results for "ranbaxy laboratories"

Cci decision on sun-ranbaxy deal before month end

The Competition Commission of India (CCI) is likely to decide on the acquisition of Ranbaxy Laboratories by Sun Pharma for $4 billion by the end of Nov 2014 . The commission had asked the companies to rectify some of the observations in ... 4 Traders, 4 days ago
Sun-Ranbaxy deal to materialise by year end PharmaBiz, 22 hours ago

42 images for ranbaxy laboratories

Sify, 1 week ago
Financial Express, 2 days ago
BusinessWeek, 1 week ago
Yahoo! Finance, 1 week ago
Reuters India, 1 week ago
Reuters India, 1 week ago
Money Today, 2 days ago
Deccan Chronicle, 3 weeks ago
Financial Express, 1 month ago
Yahoo! News, 2 weeks ago

Sanjeev Dani, Rajiv Gulati quit Ranbaxy as senior management churn continues

NEW DELHI: In a sustained churn at Ranbaxy Laboratories, Sanjeev Dani, head of global strategy, corporate and business development, and Rajiv Gulati, president of global pharma business, have quit, people familiar with the matter told ET. This ...
 Economic Times1 day ago
Money Control

US court refuses Ranbaxy plea to block ANDA nod for 2 drugs

Ranbaxy Laboratories had sued USFDA over revoking an approval to sell generic versions of Nexium and Valcyte in the US market.
 Money Control2 days ago US Court Refuses Ranbaxy Appeal to Block ANDA Nod for 2 Drugs  Outlook India2 days ago US Court Refuses Ranbaxy Laboratories Appeal To Block ANDA Nod For 2 Drugs  BioSpace2 days ago Ranbaxy Laboratories : US COURT REFUSES RANBAXY APPEAL TO BLOCK ANDA NOD  4 Traders14 hours ago
Business Today India

Us overturns ranbaxy bid to block launch of nexium, valcyte generics

The U.S. District Court of Minneapolis has denied a request by Indian drug maker Ranbaxy Laboratories to stop competitors from launching copies of Nexium and Valcyte. Nexium is a proprietary heartburn drug from AstraZeneca Plc , while ...
 4 Traders3 days ago U.S. Court Overturns Bid, Setback For Ranbaxy  The CFO Institute1 week ago US court dumps Ranbaxy's bid to stall launch of rival generics  Domain-B1 week ago Ranbaxy Fails To Block Launch Of Rival Generic Drugs  Businessworld India1 week ago

Ranbaxy Laboratories declines after setback in US Court

Ranbaxy Laboratories lost 1.15% to Rs 613.50 at 11:50 IST on BSE after the company said that D.C. Federal Court has not granted temporary restraining order to block FDA approval for other ANDAs for generic version of Nexium and Valganciclovir. ...
 Capital Market2 days ago

Ranbaxy Laboratories allots equtiy shares

This page uses frames, but your browser doesn't
 Capital Market2 days ago

RANBAXY LABORATORIES : D.C. Federal Court Refuses Ranbaxy's Appeal To Block ANDA Nod For Nexium And Valganciclovir

Ranbaxy Laboratories Ltd had filed a complaint against the FDA in D.C. Federal Court and had also asked the court for a temporary restraining order to prevent any further action by FDA until Ranbaxy's case is decided. (c) 2014 GlobalData ...
 4 Traders1 day ago US Court denies restraining order to block FDA approval for other ANDAs  Equity Bulls2 days ago Ranbaxy can't stop the FDA from yanking drug approvals over plant problems  FiercePharmaManufacturing1 week ago Ranbaxy drags US FDA to court  Business Standard India1 week ago
Business Standard India

Ranbaxy Laboratories rebounds over 6% from intra-day low

The stock moved higher by 4% to Rs 625, bouncing back 6.5% from intra-day low of Rs 587 on BSE. SI Reporter | Mumbai November 20, 2014 Last Updated at 11:56 IST Shares of Ranbaxy Laboratories have moved higher by 4% to Rs 625, bouncing back 6.5% ...
 Business Standard India1 week ago

Ranbaxy Lab drops after reports of suing USFDA for revoking drug approvals

Ranbaxy Laboratories declined 2.03% to Rs 629.10 at 15:25 IST on BSE on reports company has sued the US Food and Drug Administration for revoking approvals granted to the firm to launch copies of two drugs. Meanwhile, the S&P BSE Sensex was down 24.44 points ...
 Business Standard1 week ago
NDTV Profit

Ranbaxy to exit Nifty Junior index from November 28

ust of India | Mumbai November 18, 2014 Last Updated at 19:25 IST Drug maker Ranbaxy Laboratories is being moved out of the National Stock Exchange's CNX Nifty Junior index and would be replaced by Reliance Infrastructure. The changes have been made on ...
 Business Standard1 week ago Ranbaxy Laboratories to exit Nifty Junior index from November 28  Economic Times1 week ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - ranbaxy laboratories
Get updated on latest news & your favorite topics right in your inbox!
More     Less